Amorphous Lercanidipine Hydrochloride

Patent No. EP1856051 (titled "Amorphous Lercanidipine Hydrochloride") was filed by Recordati Industria Chimica E Farmaceutica on Feb 24, 2006. The application was issued on Nov 13, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (7)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1856051

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA
Application Number
EP06723128A
Filing Date
Feb 24, 2006
Status
Revoked
Oct 14, 2022
Publication Date
Nov 13, 2019